Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentUSH2 complex

PDZD7 USH2A

1.64e-0441102GO:1990696
GeneOntologyCellularComponentstereocilia ankle link

PDZD7 USH2A

4.06e-0461102GO:0002141
GeneOntologyCellularComponentstereocilia ankle link complex

PDZD7 USH2A

4.06e-0461102GO:0002142
Domain-

FBXW10B SEMA4B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 NUP133 ELP2 PLXNB3 ATG16L2

6.24e-07333110122.130.10.10
DomainWD40/YVTN_repeat-like_dom

FBXW10B SEMA4B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 NUP133 ELP2 PLXNB3 ATG16L2

6.65e-0733511012IPR015943
DomainSRCR

CD163 MSR1 CD5L CD163L1

6.31e-06211104PF00530
Domain-

CD163 MSR1 CD5L CD163L1

1.31e-052511043.10.250.10
DomainSR

CD163 MSR1 CD5L CD163L1

1.31e-05251104SM00202
DomainSRCR-like_dom

CD163 MSR1 CD5L CD163L1

1.54e-05261104IPR017448
DomainSRCR_1

CD163 MSR1 CD5L CD163L1

1.54e-05261104PS00420
DomainSRCR_2

CD163 MSR1 CD5L CD163L1

1.54e-05261104PS50287
DomainSRCR

CD163 MSR1 CD5L CD163L1

1.80e-05271104IPR001190
DomainWD40

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

2.26e-052591109PF00400
DomainWD40

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

2.96e-052681109SM00320
DomainWD40_repeat

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

3.32e-052721109IPR001680
DomainWD_REPEATS_1

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

3.94e-052781109PS00678
DomainWD_REPEATS_2

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

4.05e-052791109PS50082
DomainWD_REPEATS_REGION

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

4.05e-052791109PS50294
DomainWD40_repeat_dom

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

6.57e-052971109IPR017986
DomainG-protein_beta_WD-40_rep

FBXW10B FBXW10 COPB2 PWP1 ATG16L2

1.46e-04851105IPR020472
DomainFOXP-CC

FOXP2 FOXP1

2.05e-0441102PF16159
DomainFOXP-CC

FOXP2 FOXP1

2.05e-0441102IPR032354
DomainN-RASSF

RASSF7 RASSF8

2.05e-0441102IPR033593
DomainConA-like_dom

TRIM21 MEFV SVEP1 LGALS8 RFPL4B NBEAL2 USH2A

3.17e-042191107IPR013320
DomainKinase-like_dom

TNIK CDC42BPA TRPM7 SPEG SRC HIPK2 PHKG2 ACAD11 CDK13 MACF1 RPS6KL1

3.54e-0454211011IPR011009
DomainADEAMc

ADARB1 ADAD2

5.08e-0461102SM00552
DomainA_deamin

ADARB1 ADAD2

5.08e-0461102PF02137
DomainA_DEAMIN_EDITASE

ADARB1 ADAD2

5.08e-0461102PS50141
DomainA_deamin

ADARB1 ADAD2

5.08e-0461102IPR002466
DomainFN3_dom

SPEG IL22RA1 HCFC2 USH2A IL3RA MYBPC3

1.49e-032091106IPR003961
DomainExoRNase_PH_dom1

EXOSC9 GALNT8

1.50e-03101102IPR001247
DomainPRY

TRIM21 MEFV RFPL4B

2.84e-03481103SM00589
DomainPRY

TRIM21 MEFV RFPL4B

2.84e-03481103IPR006574
DomainWD40_repeat_CS

FBXW10B FBXW10 KIF21A PWP1 ATG16L2

2.86e-031641105IPR019775
DomainIg-like_fold

SEMA4B SPEG IL22RA1 KIR2DL2 HCFC2 KIR2DS1 KIR2DS3 USH2A IL3RA PLXNB3 MYBPC3

2.98e-0370611011IPR013783
DomainCNH

TNIK CDC42BPA

2.99e-03141102SM00036
DomainCNH

TNIK CDC42BPA

3.43e-03151102PF00780
DomainCNH

TNIK CDC42BPA

3.43e-03151102PS50219
DomainCNH_dom

TNIK CDC42BPA

3.43e-03151102IPR001180
DomainSer/Thr_kinase_AS

TNIK CDC42BPA SPEG HIPK2 PHKG2 CDK13 RPS6KL1

5.21e-033571107IPR008271
DomainDSRM

ADARB1 ADAD2

5.51e-03191102SM00358
DomainPROTEIN_KINASE_ST

TNIK CDC42BPA SPEG HIPK2 PHKG2 CDK13 RPS6KL1

5.61e-033621107PS00108
Domain-

SPEG IL22RA1 KIR2DL2 HCFC2 KIR2DS1 KIR2DS3 USH2A IL3RA PLXNB3 MYBPC3

5.76e-03663110102.60.40.10
DomainPROTEIN_KINASE_ATP

TNIK CDC42BPA SPEG SRC HIPK2 PHKG2 CDK13 RPS6KL1

5.78e-034591108PS00107
Pubmed

Mouse screen reveals multiple new genes underlying mouse and human hearing loss.

TNIK DMGDH ADAMTS19 EXOSC9 SRC NCF2 TRIM21 IL22RA1 ADCY9 CYFIP2 PWP1 ACSL4 NBEAL2 ZNF408 GMDS HACL1 LEPROT CSMD1 PLXNB3 ATG16L2

2.81e-0912421122030973865
Pubmed

Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis.

KIR2DL2 KIR2DS1 KIR2DS3

6.46e-076112317882223
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

FBXW10B SEMA4B FBXW10 CDC42BPA SRC DNAH2 HIPK2 PELI1 ARF4 ARF5 ACSL4 CDK13 HCFC2

6.98e-077301121334857952
Pubmed

A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex.

EXOSC9 HIPK2 STAM RASSF7 CDK13

1.16e-0657112516730941
Pubmed

Structure and intracellular localization of mouse ADP-ribosylation factors type 1 to type 6 (ARF1-ARF6).

COPB2 ARF4 ARF5

1.80e-06811238947846
Pubmed

NullHap--a versatile application to estimate haplotype frequencies from unphased genotypes in the presence of null alleles.

KIR2DL2 KIR2DS1 KIR2DS3

1.80e-068112318681957
Pubmed

New genetic associations detected in a host response study to hepatitis B vaccine.

FOXP2 CASP5 NCF2 IL22RA1 CD163 FCGBP CD5L ACAD11 MS4A1 CD163L1 GMDS MACF1 FOXP1

2.65e-068241121320237496
Pubmed

Assessment of killer cell immunoglobulinlike receptor expression and corresponding HLA class I phenotypes demonstrates heterogenous KIR expression independent of anticipated HLA class I ligands.

KIR2DL2 KIR2DS1 KIR2DS3

3.84e-0610112312559621
Pubmed

Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus.

KIR2DL2 KIR2DS1 KIR2DS3

3.84e-0610112321206914
Pubmed

Sequential ubiquitination of NLRP3 by RNF125 and Cbl-b limits inflammasome activation and endotoxemia.

CASP5 RNF213 TRIM21

5.26e-0611112331999304
Pubmed

[Genotype analysis of killer cell immunoglobulin-like receptors in Graves' disease patients].

KIR2DL2 KIR2DS1 KIR2DS3

5.26e-0611112319664392
Pubmed

Association of killer cell immunoglobulin-like receptor 2DL5 with systemic lupus erythematosus and accompanying infections.

KIR2DL2 KIR2DS1 KIR2DS3

7.00e-0612112320371502
Pubmed

Distribution of killer cell immunoglobulin-like receptors (KIR) and their HLA-C ligands in two Iranian populations.

KIR2DL2 KIR2DS1 KIR2DS3

7.00e-0612112319936734
Pubmed

Association of killer cell immunoglobulin-like receptors with primary Sjogren's syndrome.

KIR2DL2 KIR2DS1 KIR2DS3

7.00e-0612112319181658
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

CDC42BPA TRPM7 LEMD3 SRC ARFGEF1 RNF213 SRPRA ADCY9 ARF4 ARF5 EXD2 HCFC2

8.16e-067771121235844135
Pubmed

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

KIR2DL2 KIR2DS1 KIR2DS3

9.08e-0613112319934297
Pubmed

Different KIRs confer susceptibility and protection to adults with latent autoimmune diabetes in Latvian and Asian Indian populations.

KIR2DL2 KIR2DS1 KIR2DS3

9.08e-0613112319120281
Pubmed

[Study on the polymorphism of killer cell immunoglobulin like receptor (KIR) gene with systemic lupus erythematosus of North population in China].

KIR2DL2 KIR2DS1 KIR2DS3

9.08e-0613112318687225
Pubmed

Differential and Overlapping Pattern of Foxp1 and Foxp2 Expression in the Striatum of Adult Mouse Brain.

FOXP2 FOXP1

1.03e-052112230031127
Pubmed

Foxp2 regulates anatomical features that may be relevant for vocal behaviors and bipedal locomotion.

FOXP2 FOXP1

1.03e-052112230104377
Pubmed

B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis.

FBN1 MS4A1

1.03e-052112216936269
Pubmed

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies.

SRC MS4A1

1.03e-052112225517315
Pubmed

c-Src activates both STAT1 and STAT3 in PDGF-stimulated NIH3T3 cells.

SRC STAT1

1.03e-05211229344858
Pubmed

Assignment of CD163B, the gene encoding M160, a novel scavenger receptor, to human chromosome 12p13.3 by in situ hybridization and somatic cell hybrid analysis.

CD163 CD163L1

1.03e-052112211124526
Pubmed

Investigating protein-protein interactions in live cells using bioluminescence resonance energy transfer.

FOXP2 FOXP1

1.03e-052112224893771
Pubmed

Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction.

FOXP2 FOXP1

1.03e-052112215056695
Pubmed

A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.

FOXP2 FOXP1

1.03e-052112225853299
Pubmed

Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex.

KIR2DL2 KIR2DS1

1.03e-052112219959527
Pubmed

FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

FOXP2 FOXP1

1.03e-052112227224915
Pubmed

Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors.

FOXP2 FOXP1

1.03e-052112211358962
Pubmed

Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.

FOXP2 FOXP1

1.03e-052112228741757
Pubmed

FBXW10 promotes hepatocarcinogenesis in male patients and mice.

FBXW10B FBXW10

1.03e-052112231400758
Pubmed

The aberrant expression of stimulatory and inhibitory killer immunoglobulin-like receptors in NK- and NKT-cells contributes to lupus.

KIR2DL2 KIR2DS1

1.03e-052112224839813
Pubmed

Interaction of brefeldin A-inhibited guanine nucleotide-exchange protein (BIG) 1 and kinesin motor protein KIF21A.

KIF21A ARFGEF1

1.03e-052112219020088
Pubmed

Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses.

ARF4 ARF5

1.03e-052112222105072
Pubmed

Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic mice.

FBXW10B FBXW10

1.03e-052112237450367
Pubmed

Mechanism of Stat1 in the neuronal Ca2+ overload after intracerebral hemorrhage via the H3K27ac/Trpm7 axis.

TRPM7 STAT1

1.03e-052112235642851
Pubmed

STAT1 suppresses the transcriptional activity of TRIM21 in gastric cancer.

TRIM21 STAT1

1.03e-052112237639009
Pubmed

Compensation between FOXP transcription factors maintains proper striatal function.

FOXP2 FOXP1

1.03e-052112238761373
Pubmed

Two functional forms of ACRBP/sp32 are produced by pre-mRNA alternative splicing in the mouse.

ACRBP ACR

1.03e-052112223426433
Pubmed

Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.

FOXP2 FOXP1

1.03e-052112226647308
Pubmed

Frequencies of killer immunoglobulin-like receptor genotypes influence susceptibility to spontaneous abortion.

KIR2DL2 KIR2DS1 KIR2DS3

1.15e-0514112319875891
Pubmed

[Genotype and haplotype analysis of killer cell immunoglobulin-like receptors in ankylosing spondylitis].

KIR2DL2 KIR2DS1 KIR2DS3

1.15e-0514112319489269
Pubmed

Multiple sclerosis associates with LILRA3 deletion in Spanish patients.

KIR2DL2 KIR2DS1 KIR2DS3

1.15e-0514112319421224
Pubmed

Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population.

KIR2DL2 KIR2DS1 KIR2DS3

1.15e-0514112315896204
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Caucasian population of southern Brazil.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112320082646
Pubmed

Killer cell immunoglobulin-like receptors in HLA-B27-associated acute anterior uveitis, with and without axial spondyloarthropathy.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112319850842
Pubmed

[Killer cell immunoglobin-like receptor and its ligand gene polymorphisms in Hunan Han patients with type 1 diabetes].

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112320356536
Pubmed

Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112319926642
Pubmed

Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112320207982
Pubmed

Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112319493232
Pubmed

Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112320643584
Pubmed

KIR genes polymorphism in Argentinean Caucasoid and Amerindian populations.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112317498266
Pubmed

Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.

KIR2DL2 KIR2DS1 KIR2DS3

1.44e-0515112319326408
Pubmed

The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.

TNIK CDC42BPA TRPM7 LEMD3 SRC ARFGEF1 ADCY9 NBEAL2 EXD2 TACSTD2

1.61e-055691121030639242
Pubmed

Killer cell immunoglobulin-like receptor gene-cluster 3DS1-2DL5-2DS1-2DS5 predisposes susceptibility to Vogt-Koyanagi-Harada syndrome in Japanese individuals.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112319897003
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Java, Kalimantan, Timor and Irian Jaya.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112319000141
Pubmed

Diversity of killer cell immunoglobulin-like receptor genes in Indonesian populations of Sumatra, Sulawesi and Moluccas Islands.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112320670355
Pubmed

Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112318668235
Pubmed

Distribution of killer cell immunoglobulin-like receptor (KIR) genotypes in patients with familial Mediterranean fever.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112319309280
Pubmed

Loss of Intercalated Cells (ITCs) in the Mouse Amygdala of Tshz1 Mutants Correlates with Fear, Depression, and Social Interaction Phenotypes.

FOXP2 ADORA2A FOXP1

1.77e-0516112329255003
Pubmed

[Polymorphism of killer cell immunoglobulin-like receptors gene family in Zhejiang Han population].

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112316403292
Pubmed

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112319527230
Pubmed

Polymorphisms of KIR gene and HLA-C alleles: possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112320652381
Pubmed

Influence of activating and inhibitory killer immunoglobulin-like receptors on predisposition to recurrent miscarriages.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112319279038
Pubmed

No association of KIR genes with Behcet's disease.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112317868255
Pubmed

A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112318643961
Pubmed

Report from the killer immunoglobulin-like receptor (KIR) anthropology component of the 15th International Histocompatibility Workshop: worldwide variation in the KIR loci and further evidence for the co-evolution of KIR and HLA.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112320331834
Pubmed

HLA-DQA1*0505 sharing and killer immunoglobulin-like receptors in sub fertile couples: report from the 15th International Histocompatibility Workshop.

KIR2DL2 KIR2DS1 KIR2DS3

1.77e-0516112320210919
Pubmed

[Effects of killer immunoglobulin-like receptor and human leukocyte antigen class I ligand on the prognosis of related donor hematopoietic stem cell transplantation].

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319968064
Pubmed

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112320878400
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112320650299
Pubmed

Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319032228
Pubmed

The beneficial impact of missing KIR ligands and absence of donor KIR2DS3 gene on outcome following unrelated hematopoietic SCT for myeloid leukemia in the Chinese population.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112320173784
Pubmed

The role of killer immunoglobulin-like receptor haplotypes on the outcome of unrelated donor haematopoietic SCT for thalassaemia.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112320173792
Pubmed

Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112320483367
Pubmed

[Analysis of natural killer cell immunoglobulin-like receptor genes in Chinese].

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319218127
Pubmed

KIR genes and KIR ligands affect occurrence of acute GVHD after unrelated, 12/12 HLA matched, hematopoietic stem cell transplantation.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319169284
Pubmed

Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319450876
Pubmed

Distribution of killer-cell immunoglobulin-like receptor genes in Eastern mainland Chinese Han and Taiwanese Han populations.

KIR2DL2 KIR2DS1 KIR2DS3

2.14e-0517112319761533
Pubmed

Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.

FOXP2 RBBP5 COPB2 PRPF8 STAT1 CYFIP2 ACSL4 PHKG2 NUP133 FOXP1 TOP2A SMAD4

2.15e-058571121225609649
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

SEMA4B FOXP2 TRIM21 PRPF8 CYFIP2 SYNJ1 MACF1 TOP2A

2.19e-05358112832460013
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

EXOSC9 CDC42BPA PCNX3 LEMD3 RBBP5 SRPRA STAT1 CYFIP2 LGALS8 PWP1 ACAD11 CDK13 EXD2 MACF1 HCFC2 TACSTD2

2.47e-0514971121631527615
Pubmed

Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112319630074
Pubmed

Signatures of natural selection and coevolution between killer cell immunoglobulin-like receptors (KIR) and HLA class I genes.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112320200544
Pubmed

Combination of KIR 2DL2 and HLA-C1 (Asn 80) confers susceptibility to type 1 diabetes in Latvians.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112319046302
Pubmed

Association of killer cell immunoglobulin-like receptors and human leukocyte antigen-C genotypes in South Brazilian with type 1 diabetes.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112320580654
Pubmed

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112320519398
Pubmed

Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.

KIR2DL2 KIR2DS1 KIR2DS3

2.56e-0518112319846535
Pubmed

E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.

RBBP5 KIF21A COPB2 DNAH2 RNF213 SRPRA PRPF8 ARF5 SARS1 ZNF408 PLXNB3

2.68e-057361121129676528
Pubmed

KIR and HLA gene combinations in Vogt-Koyanagi-Harada disease.

KIR2DL2 KIR2DS1 KIR2DS3

3.03e-0519112318571006
Pubmed

Association between killer-cell immunoglobulin-like receptor genotypes and leprosy in Brazil.

KIR2DL2 KIR2DS1 KIR2DS3

3.03e-0519112318778326
Pubmed

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

KIR2DL2 KIR2DS1 KIR2DS3

3.03e-0519112320600442
Pubmed

Killer cell immunoglobulin-like receptor gene diversity in a Southern Brazilian population from the state of Paraná.

KIR2DL2 KIR2DS1 KIR2DS3

3.03e-0519112318848853
Pubmed

Deletion of Class II ADP-Ribosylation Factors in Mice Causes Tremor by the Nav1.6 Loss in Cerebellar Purkinje Cell Axon Initial Segments.

ARF4 ARF5

3.08e-053112231201232
Pubmed

GBF1-Arf-COPI-ArfGAP-mediated Golgi-to-ER transport involved in regulation of lipid homeostasis.

ARF4 ARF5

3.08e-053112222185782
Pubmed

Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues.

FOXP2 FOXP1

3.08e-053112214516685
Pubmed

Human and Giardia ADP-ribosylation factors (ARFs) complement ARF function in Saccharomyces cerevisiae.

ARF4 ARF5

3.08e-05311221447192
Pubmed

PDZD7 is a modifier of retinal disease and a contributor to digenic Usher syndrome.

PDZD7 USH2A

3.08e-053112220440071
Pubmed

Type I Interferon Induced Epigenetic Regulation of Macrophages Suppresses Innate and Adaptive Immunity in Acute Respiratory Viral Infection.

STAT1 SETDB2

3.08e-053112226709698
Cytoband19q13.4

CACNG8 KIR2DL2 KIR2DS1 KIR2DS3

4.38e-0579112419q13.4
Cytoband12p13.3

CD163 CD163L1 GALNT8

5.47e-0530112312p13.3
Cytoband3q23

RBP2 COPB2 GK5

1.74e-044411233q23
CytobandEnsembl 112 genes in cytogenetic band chr3q23

RBP2 COPB2 GK5

5.05e-04631123chr3q23
GeneFamilyWD repeat domain containing

FBXW10B FBXW10 RBBP5 KIF21A COPB2 PWP1 NBEAL2 ELP2 ATG16L2

2.32e-06262809362
GeneFamilyCD molecules|Killer cell immunoglobulin like receptors

KIR2DL2 KIR2DS1 KIR2DS3

6.49e-0518803620
GeneFamilyFibronectin type III domain containing|USH2 complex

PDZD7 USH2A

1.15e-0448021244
GeneFamilyC2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors

CD163 MSR1 CD163L1

2.26e-04278031253
GeneFamilyAdenosine deaminases acting on RNA

ADARB1 ADAD2

5.32e-0488021303
GeneFamilyRas association domain family

RASSF7 RASSF8

8.50e-04108021198
GeneFamilyWD repeat domain containing|F-box and WD repeat domain containing

FBXW10B FBXW10

1.04e-0311802559
CoexpressionDESCARTES_FETAL_ADRENAL_MYELOID_CELLS

CASP5 NCF2 MEFV CD163 MSR1 CD5L CD163L1 RAB39A

1.35e-061851128M40148
CoexpressionGSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP

TNIK SEMA4B TRPM7 RNF213 PELI1 STAT1 IL3RA

9.41e-061721127M2945
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2|Striatum / BrainAtlas - Mouse McCarroll V32

PELI1 PMEL ARF4 FCGBP PLXNB3

4.52e-069811057a62a77ca83153dacff4d02d6e32104227d0980d
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr-Polydendrocye.Tnr.Pdgfa_(Pdgfa)|Striatum / BrainAtlas - Mouse McCarroll V32

PELI1 PMEL ARF4 FCGBP PLXNB3

4.52e-0698110526250ea4171a0557a67505839cf79d3fe4d9d41a
ToppCellStriatum-Macroglia-POLYDENDROCYTE-P1-P1_2-Tnr|Striatum / BrainAtlas - Mouse McCarroll V32

PELI1 PMEL ARF4 FCGBP PLXNB3

4.52e-0698110542875d16ae9fcbaf988cd71be82568f2f862f2dd
ToppCell3'_v3-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

CASP5 NCF2 MEFV MSR1 IL3RA MYBPC3

7.12e-061871106c20689022569640ebc4a878e3fe146b86fe9b386
ToppCellRV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper

TNIK TRPM7 KIF21A KLHL7 SH3RF2 MYBPC3

7.12e-06187110678cdcf8bc141d3b155c3c8af908431fc419c4d08
ToppCellRV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper

TNIK TRPM7 KIF21A KLHL7 SH3RF2 MYBPC3

7.57e-0618911069c1debd65c13d63fd4f3158917d621b44b714c26
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.

FOXP2 GRM1 SYT10 ACSL4 CACNG8 FOXP1

7.80e-0619011066e92c78799f34b31d098854503c796edb0dc7f80
ToppCellRV-08._Macrophage|World / Chamber and Cluster_Paper

RNF213 PELI1 CD163 MSR1 CD163L1 TOP2A

8.28e-061921106a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCellAdult-Immune-alveolar_macrophage_(MARCO_positive)-D122|Adult / Lineage, Cell type, age group and donor

HIPK2 NCF2 CD163 MSR1 CD5L CD163L1

8.53e-061931106cc1b6d3bf56e4a88f6fe23dd036a83cf5538c958
ToppCellChildren_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

PELI1 CD163 MSR1 CD163L1 RAB39A ATG16L2

8.78e-061941106663e7e7fe48157e808b4f1a0ea6ad41944e857a2
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF21A ARFGEF1 HMGCR CYFIP2 SYNJ1 MACF1

9.04e-0619511063e519cffa6144a62b06124642a14c9ff39b76554
ToppCellControl_saline-Hematopoietic_Myeloid-Monocytes,_Macrophages|Control_saline / Treatment groups by lineage, cell group, cell type

ACRBP NCF2 MEFV CD163 MSR1 CD163L1

9.86e-061981106684f2dd5db889f118b5218ee23733cc1361272c2
ToppCellControl_saline-Hematopoietic_Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|Control_saline / Treatment groups by lineage, cell group, cell type

ACRBP NCF2 MEFV CD163 MSR1 CD163L1

9.86e-061981106c15ab0660a6de445a83396cf70860ea39868914d
ToppCellmild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TNIK ARFGEF1 RNF213 GK5 CDK13 MACF1

1.01e-051991106f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCellCOVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

HIPK2 RNF213 GK5 CYFIP2 MACF1 KIR2DL2

1.01e-051991106df4f7d5be099e3e6054f3b812ccf70251664e4c0
ToppCellmLN-Macrophage-Macrophage|mLN / Region, Cell class and subclass

ZNF205 NCF2 CD163 MSR1 CD5L CD163L1

1.01e-0519911066bbec8450afb30347b07da28401a698fc51a3c53
ToppCellCOVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

HIPK2 RNF213 GK5 CYFIP2 MACF1 KIR2DL2

1.01e-051991106ed35d747f11f6ea6a5cb7061057f0a98d9e0db99
ToppCellmLN-(6)_Macrophage-(60)_Macrophage|mLN / shred on region, Cell_type, and subtype

ZNF205 NCF2 CD163 MSR1 CD5L CD163L1

1.01e-0519911061ea28b832c6173b1b58da432aaf21e6cd291561e
ToppCellmLN-Macrophage|mLN / Region, Cell class and subclass

NCF2 MEFV CD163 MSR1 CD5L CD163L1

1.04e-05200110668d709afd226241e002dae6d6820bccd1cfd87a1
ToppCellmLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype

NCF2 MEFV CD163 MSR1 CD5L CD163L1

1.04e-0520011066dcba82a7d322102bae205543086e84c7655b3e0
ToppCellfacs-Skin-Anagen-3m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCF2 MEFV CD163 MSR1 CD5L

2.83e-051431105250f60f06f262f00acd14b09b3ef90dbb9759336
ToppCellfacs-Skin-Anagen-3m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCF2 MEFV CD163 MSR1 CD5L

2.83e-0514311050c7c0d7ca040e87412295672cd1f065c0e941391
ToppCellfacs-Skin-Anagen-3m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

NCF2 MEFV CD163 MSR1 CD5L

2.83e-05143110527f4896276342758651fe7a80d7408ac5e1be9c0
ToppCellCOVID-19_Moderate-multiplets|COVID-19_Moderate / disease group, cell group and cell class

GK5 SH3RF2 NBEAL2 MACF1 TACSTD2

3.23e-051471105baf15c773d7751bc6f64d4974a22738626f2b3ff
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells)

NCF2 CD163 MSR1 ADORA2A CD5L

4.29e-0515611051a0e081284a99c1b345990775015b8a2fa469496
ToppCellTCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-6|TCGA-Stomach / Sample_Type by Project: Shred V9

TNIK FBXW10B PCNX3 CACNG8 TOP2A

4.70e-051591105655c0749c238bd68cb797adb83e25a23b8a3cc9d
ToppCell10x5'-GI_small-bowel-Myeloid_Mac-Macrophage|GI_small-bowel / Manually curated celltypes from each tissue

NCF2 CD163 MSR1 CD163L1 IL3RA

6.10e-051681105d5b746d6083c2c8155a0ea345ea368bf6617d5ca
ToppCellMild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)

PELI1 ADARB1 MS4A1 MACF1 FOXP1

6.27e-051691105c3a6179a64589a370108fea809b157839347759c
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CDC42BPA NCF2 MSR1 FCGBP TACSTD2

6.27e-051691105d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCellCOVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type

CD163 MSR1 FCGBP CD163L1 MYBPC3

6.45e-0517011054232fe937909f93d3736988c707b8f95ce993398
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage|390C / Donor, Lineage, Cell class and subclass (all cells)

NCF2 CD163 MSR1 CD163L1 IL3RA

6.45e-0517011053a7121d045f9ae54583b0f5f7436abf3665a1bce
ToppCelldroplet-Liver-LIVER-NPC-1m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CYFIP2 ADORA2A CD163L1 NBEAL2 TECPR1

6.45e-051701105bcbe5c44ef708c5f01dc7dd9aec7b436e1a62d56
ToppCellMonocytes-IFN-activated_Monocytes|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues

NCF2 CD163 MSR1 RERGL IL3RA

6.63e-051711105df1b631618839bee4a18a2ba9c730321e5015f36
ToppCell390C-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

DMGDH ZNF205 CD163 MSR1 ST6GALNAC3

6.63e-0517111057c8304573b892ef9ea4e048cba9ea9fbab848dcd
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass

NCF2 CD163 MSR1 CD5L IL3RA

7.01e-0517311054efa0878ed1ede8fa5d6c191a76d4f70558ba761
ToppCell5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

RNF213 NCF2 CD163 MSR1 ATG16L2

7.20e-051741105d5c22b43531414951666ee7542a66ed9380e2d14
ToppCelldroplet-Bladder-Unstain-18m-Hematologic-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CD163 ADORA2A ST6GALNAC3 CD163L1 PLXNB3

7.20e-051741105773329bb91b97578df138446cf62101dd0dad758
ToppCell10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

COLCA1 TRIM21 ADARB1 CYFIP2 NBEAL2

7.40e-051751105a3f8c54c77bce9b035a4835945ab341909be4946
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

7.81e-051771105cdad5a2f672a7f07c05669bfcaf1ec74defd3de7
ToppCellLPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

7.81e-051771105991ae76bb615392d84aeb89886148fa42c1c649c
ToppCell10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD5L CD163L1

7.81e-051771105945b2d0723a0a35c767604ae607d2c2d53bf0c82
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

NCF2 CD163 MSR1 CD163L1 RAB39A

8.02e-05178110524e8c62060455159235985f456af0c5023a7f3f5
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

NCF2 CD163 MSR1 CD163L1 RAB39A

8.02e-0517811054f1cc954d4d9b5b2b75a4cf995ba81e2ada27084
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ARFGEF1 CASP5 CD163 MSR1 ACSL4

8.23e-05179110587f608b137aae34572b150492a83a3a127cff40b
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

NCF2 MEFV CD163 MSR1 RAB39A

8.45e-05180110566c7b02d85e32ba3e7530d0c4aff17e7525ccdd8
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

8.45e-05180110597241f62ee133dcb0d4855ffda5dd1349de9f7b2
ToppCellLPS-IL1RA-Myeloid-Monocytes,_Macrophages|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

8.45e-05180110541896546cd1cc458e08c0d4e19aa4860e5d4fcd6
ToppCellnormal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass

CASP5 NCF2 MEFV CD163 MYBPC3

8.67e-051811105921e917f83105896ad8918dc134b871708024021
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

8.90e-051821105d5d6bc16458bc665e7ad6669040d79f73f640044
ToppCellLPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

NCF2 MEFV CD163 MSR1 RAB39A

8.90e-0518211050b59ead4bb4486c7ec2ee90b94ee3a09905612c5
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPEG NCF2 ADCY9 ADORA2A RERGL

9.37e-05184110589ae8bf1a6c2d355d279d23a5e24a08d9ec2334e
ToppCellCOPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class

PELI1 GK5 MEFV ST6GALNAC3 CSMD1

9.37e-051841105ceec41ed5636032aaf7716d1203816ea58bd39bd
ToppCellfacs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNIK GALM PELI1 PMEL TECPR1

9.37e-051841105c37c623c4a5ff1628486d8a6461fa355ad5c264c
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SPEG NCF2 ADCY9 ADORA2A RERGL

9.37e-05184110534c84ac9a32eaf96f45b79485119cad65905817d
ToppCellLPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 KIF21A GK5 CYFIP2 ACSL4

9.37e-051841105ab2f06906fc7a9931dfa0864ef506832b07fb93e
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 KIF21A GK5 CYFIP2 ACSL4

9.61e-051851105fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA4B MS4A1 MACF1 FOXP1 ATG16L2

9.61e-051851105eb338fcda0b237c2e0b9b4b0daf51febbfe1d79c
ToppCellfacs-Marrow-B-cells-3m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SEMA4B MS4A1 MACF1 FOXP1 ATG16L2

9.61e-051851105c31bb53852caf36964b83b28bcaee07b679da779
ToppCell3'_v3-lymph-node_spleen-Myeloid_Monocytic-Nonclassical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue

SRC CASP5 NCF2 MSR1 IL3RA

9.86e-051861105d7da5edb2ee36f96cdd7e27eb9afcc1cbfd52bb6
ToppCell10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue

ACRBP CASP5 NCF2 MEFV RAB39A

9.86e-051861105a16ecf70271894a842925f232009e2623d16947e
ToppCellLPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 KIF21A GK5 CYFIP2 ACSL4

9.86e-051861105e83718fabb057100835d3357df407f283d23fe16
ToppCellFetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

CD163 MSR1 CD163L1 SLC38A7 RAB39A

1.01e-04187110539b99f46b723f7f3c44880d7fe8642cbad558b8a
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

DMGDH FOXP2 KIF21A SYT10 FCGBP

1.01e-041871105c41a2c81dd2ceef303f39f699032aa7d6ea67cf0
ToppCellLPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

FOXP2 KIF21A GK5 CYFIP2 ACSL4

1.04e-0418811054bdf8d49af0e9da349b16e3f012e1b0eec04cc4f
ToppCellwk_20-22-Hematologic-Myeloid-APOE+_Mac2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

CD163 MSR1 FCGBP CD5L CD163L1

1.06e-041891105e189ef6066f87177d758f0e3ed9a17e01031a391
ToppCell390C-Myeloid-Macrophage-FABP4+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells)

CASP5 NCF2 CD163 MSR1 CD5L

1.06e-0418911053b5e1a8d5c1e1fa2124f64f212e9c6b8f1b7d7da
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FOXP2 KIF21A RASSF7 SH3RF2 TACSTD2

1.09e-04190110547e07ea22733306d8885ee9e5f0b033e2f5e2afb
ToppCellfacs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

FOXP2 KIF21A RASSF7 SH3RF2 TACSTD2

1.09e-041901105261b8afddfdcba4f70b50df126cef7ad00a0aae0
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FOXP2 HIPK2 GMDS LEPROT TACSTD2

1.09e-041901105b855b8b7d3439023390ca44629c1a99f5d4c6801
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

FOXP2 HIPK2 GMDS LEPROT TACSTD2

1.09e-041901105a5db902ad112a0c0a0a7f1a2e38718bb3bd11412
ToppCellControl-Myeloid|Control / group, cell type (main and fine annotations)

NCF2 CD163 MSR1 CD5L CD163L1

1.12e-0419111059c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell3'_v3-blood-Myeloid_Monocytic-Nonclassical_monocytes|blood / Manually curated celltypes from each tissue

SRC CASP5 MSR1 CD5L IL3RA

1.12e-04191110544a797b39254cbfa5c2bad8155436adfd3019bb0
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

TNIK TRPM7 KIF21A KLHL7 MYBPC3

1.14e-041921105ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

TNIK ARFGEF1 RNF213 MACF1 FOXP1

1.14e-04192110547646d7e4990be85072987f92bf18d52f8da752e
ToppCellRV-08._Macrophage|RV / Chamber and Cluster_Paper

PELI1 CD163 MSR1 CD163L1 TOP2A

1.17e-04193110512bf98a280f87e4d8f0c6887dfc855da72e47ac1
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

SEMA4B HIPK2 PELI1 PWP1 MS4A1

1.17e-0419311059f798a1bbd9f076c3122d02ed28418c18bb7a369
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NCF2 CD163 MSR1 CD163L1 RAB39A

1.17e-041931105f597fefc54327a1ad136e2f66b6e81cc5c761eb7
ToppCellChildren_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor

HIPK2 NCF2 CD163 MSR1 CD5L

1.20e-04194110569cf7c989ac355c459db13f9d4267b55adc3c174
ToppCellCOPD-Myeloid-Macrophage|World / Disease state, Lineage and Cell class

PELI1 CD163 MSR1 ST6GALNAC3 CSMD1

1.20e-0419411057d682408e9a6239a4e47befc9376e760cc3d133a
ToppCell367C-Myeloid-Macrophage-FABP4+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells)

NCF2 CD163 MSR1 CD5L IL3RA

1.20e-04194110540c91ed945bd5990a0dbf2090d37a660b19aaab2
ToppCellLA-08._Macrophage|World / Chamber and Cluster_Paper

PELI1 CD163 MSR1 CD163L1 RAB39A

1.20e-041941105c1805572bcc11b1cd29083329d7b5911489fb758
ToppCellcontrol-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GALM CASP5 RNF213 TRIM21 STAT1

1.20e-041941105267e213e8efe53aadfe553a2ca010a0e3b4b8939
ToppCellControl-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class

TNIK PELI1 STAM ACSL4 MACF1

1.20e-041941105a01de094f7bfd099bcbb2f94224690a2efb887b4
ToppCellLA-08._Macrophage|LA / Chamber and Cluster_Paper

PELI1 CD163 MSR1 CD163L1 RAB39A

1.23e-0419511055e1d5bdb8874091f5a2b1d0a8cc9008165718a97
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KIF21A ARFGEF1 HMGCR CYFIP2 MACF1

1.23e-0419511057796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD5L CD163L1

1.26e-041961105e0447ad2efb021b63c7fef000d39b6b21fbe6113
ToppCell10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD5L CD163L1

1.26e-0419611053bca88eede3dd7368715ced02e3bacd1e3e82cab
ToppCell10x3'2.3-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD5L CD163L1

1.26e-04196110588517bb92be2f05c1e1ad94af22ac10d8c5c13c7
ToppCellCOVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

TNIK CYFIP2 MS4A1 MACF1 FOXP1

1.29e-041971105c672915f8c8c1e948d251f6eaf9f84a5600c1193
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

NCF2 CD163 MSR1 CD163L1 RAB39A

1.29e-0419711058af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell(3)_Macrophage_MARCOneg|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

NCF2 CD163 MSR1 FCGBP CD163L1

1.29e-041971105b0ee2ce1179b60b4542559acb300a34295277dbc
ToppCell5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

RNF213 CD163 MSR1 CD163L1 ATG16L2

1.29e-04197110510190b877bf46ba2163d203df9dd3b498c66e52f
ToppCell(6)_Macrophage|World / shred on Cell_type and subtype

NCF2 MEFV CD163 MSR1 CD163L1

1.29e-041971105010b275d4da4a896175ad7fbaa96d1dc11a0b744
ToppCell10x3'2.3-week_14-16-Myeloid_macrophage-stroma-stromal_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD5L CD163L1

1.29e-04197110572775eb6c24cfb956436642ac9cd6e4d5c01ea5f
ToppCellBronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intermediate|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FBXW10B PELI1 CD163 MSR1 CD163L1

1.29e-041971105e2983ae16c72371fbf0e5c123de9f4d900724e5e
ToppCellsevere-Myeloid-Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

GALM CASP5 RNF213 TRIM21 STAT1

1.29e-041971105c8a90d82170cf20e14aebecddcf7cc0ca56cda87
ToppCellmild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

TNIK PELI1 STAM STAT1 FOXP1

1.29e-04197110539800e6e83f2d333b753d121c7aeb2912b91faa2
ToppCellcontrol-Myeloid-Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs

CASP5 RNF213 NCF2 TRIM21 STAT1

1.29e-0419711058819db1550bf14566c6d33d97f7f83419e867ace
ToppCell10x5'v1-week_12-13-Myeloid_macrophage-stroma-stromal_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

CD163 MSR1 FCGBP CD163L1 SLC38A7

1.29e-041971105075044c17f1c52008cd3c292c15cbf485b50411e
ToppCellPBMC-Mild-Lymphocyte-T/NK-Other_T-gd_T-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

TNIK KIF21A RNF213 CYFIP2 MACF1

1.32e-041981105a1b310274aa9b3d2aa1fe9488d67422bf4ac81d2
DrugAmiprilose hydrochloride [60414-06-4]; Up 200; 11.8uM; PC3; HT_HG-U133A

TNIK SPEG ADARB1 LGALS8 CDK13 KHK LEPROT SMAD4 MYBPC3

5.12e-0719611194000_UP
DrugTalampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; PC3; HT_HG-U133A

SPEG HIPK2 RASSF7 ADCY9 LGALS8 PHKG2 NBEAL2 ABCC10

6.05e-0619911187254_DN
DrugEpivincamine [6835-99-0]; Up 200; 11.2uM; MCF7; HT_HG-U133A

CDC42BPA SRC GRM1 MSR1 FBN1 SYNJ1 CDK13 KLK2

6.28e-0620011186838_UP
Drugmetrifudil

HIPK2 STAT1 ADORA2A

1.32e-05101113CID000065710
DiseaseUsher syndrome type 2A (is_implicated_in)

PDZD7 USH2A

1.35e-0521092DOID:0110838 (is_implicated_in)
DiseaseUSHER SYNDROME, TYPE IIA

PDZD7 USH2A

1.35e-0521092276901
DiseaseUSHER SYNDROME, TYPE IIA

PDZD7 USH2A

1.35e-0521092C1848634
DiseaseUsher syndrome type 2A

PDZD7 USH2A

1.35e-0521092cv:C1848634
DiseaseUsher syndrome type 2

PDZD7 USH2A

4.05e-0531092C0339534
Diseasespecific developmental disorder (implicated_via_orthology)

FOXP2 FOXP1

8.07e-0541092DOID:0060038 (implicated_via_orthology)
Diseasechildhood trauma measurement

FOXP2 ST6GALNAC3 FOXP1

9.38e-05241093EFO_0007979
Diseasecortical surface area measurement

TNIK ADAMTS19 FOXP2 PCNX3 RBBP5 HIPK2 HMGCR GK5 SVEP1 STAT1 FBN1 ACAD11 MACF1 FOXP1 RPS6KL1

1.28e-04134510915EFO_0010736
Diseasekallikrein-7 measurement

CD163 CD163L1

1.34e-0451092EFO_0008195
DiseaseUsher Syndrome, Type II

PDZD7 USH2A

1.34e-0451092C1568249
Diseaseintellectual disability (is_implicated_in)

ACSL4 SARS1 CDK13

1.85e-04301093DOID:1059 (is_implicated_in)
Diseasefacial hair thickness measurement

FOXP2 GMDS MACF1

2.25e-04321093EFO_0007823
Diseasearteriovenous malformations of the brain (implicated_via_orthology)

LEMD3 SARS1

2.81e-0471092DOID:0060688 (implicated_via_orthology)
DiseaseC-reactive protein measurement

DMGDH GK5 ADARB1 IL22RA1 ADCY9 CYFIP2 KLHL7 MACF1 HACL1 FOXP1 LEPROT ATG16L2 MYBPC3

5.13e-04120610913EFO_0004458
Diseaseaspartate aminotransferase measurement

TRPM7 RBBP5 DNAH2 RNF213 STAM CD163 ST6GALNAC3 LEPROT CSMD1 ATG16L2 MYBPC3

5.26e-0490410911EFO_0004736
Diseasegastroesophageal reflux disease

FOXP2 ADARB1 FOXP1 CSMD1

5.46e-041011094EFO_0003948
DiseaseThromboembolism

TRIM21 CSMD1 ATG16L2

5.82e-04441093HP_0001907
DiseaseRetinitis Pigmentosa

PRPF8 KLHL7 ZNF408 USH2A

6.10e-041041094C0035334
Diseasecerebral cavernous malformation (implicated_via_orthology)

CDC42BPA RNF213

7.28e-04111092DOID:0060669 (implicated_via_orthology)
DiseaseBarrett's esophagus (is_implicated_in)

MSR1 FOXP1

7.28e-04111092DOID:9206 (is_implicated_in)
Diseasepulmonary fibrosis (implicated_via_orthology)

STAT1 SMAD4

8.71e-04121092DOID:3770 (implicated_via_orthology)
Diseasebrain measurement, neuroimaging measurement

TNIK ADAMTS19 FOXP2 RBBP5 ACAD11 SLC38A7 MACF1 FOXP1

1.01e-035501098EFO_0004346, EFO_0004464
DiseaseAdenocarcinoma Of Esophagus

FOXP1 SMAD4

1.20e-03141092C0279628
Diseasetuberculosis

KIF21A RERGL SH3RF2 FTHL17 CSMD1

1.27e-032161095MONDO_0018076
Diseasecardiovascular disease

HIPK2 HMGCR SVEP1 ADCY9 GMDS ABCC10 MYBPC3

1.57e-034571097EFO_0000319
Diseaseunipolar depression, bipolar disorder, schizophrenia

ADAMTS19 FOXP2

2.46e-03201092EFO_0003761, MONDO_0004985, MONDO_0005090
Diseasetaurocholate measurement

CDC42BPA FOXP1

2.46e-03201092EFO_0010538
Diseaseglomerulonephritis (biomarker_via_orthology)

FBN1 MS4A1

2.46e-03201092DOID:2921 (biomarker_via_orthology)
DiseaseRetinitis pigmentosa

PRPF8 KLHL7 USH2A

2.63e-03741093cv:C0035334
DiseaseLiver carcinoma

HMGCR STAT1 CD163 ACSL4 CD5L CSMD1 TOP2A

2.80e-035071097C2239176

Protein segments in the cluster

PeptideGeneStartEntry
LAQQKGVEGTWVDIC

ACSL4

626

O60488
WACKGTVAGVILERE

ADAD2

231

Q8NCV1
VKWQEEEEGLRLVCG

ATG16L2

91

Q8NAA4
LNCIWKIIVTEGSGI

CSMD1

1826

Q96PZ7
VTGTRAKGIIAICWV

ADORA2A

116

P29274
VVGITSWGVGCARAK

ACR

256

P10323
QEIVKTGLWVGDCFI

COPB2

521

P35606
IRKPECQGWESGLVA

FTHL17

86

Q9BXU8
RIWEVIGDHFNKVGC

ARFGEF1

1186

Q9Y6D6
LATKGCEDVRVSGWL

ACRBP

446

Q8NEB7
ICFTVWDVGGQDKIR

ARF5

61

P84085
NRLVSGGRDCQVKVW

FBXW10

506

Q5XX13
HRCEGRVEVEQKGQW

CD5L

31

O43866
RVEVEQKGQWGTVCD

CD5L

36

O43866
GRVEVKFQERWGTIC

CD163L1

166

Q9NR16
LVIAGIVENEWKRTC

MS4A1

206

P11836
DWGKRCVDKFDIIGI

CDK13

696

Q14004
RAVSKIVDWAIQVCG

ACAD11

716

Q709F0
SVGEGWKRRTVICHQ

R3HCC1

66

Q9Y3T6
KVWVDGIQRVVCGVS

RASSF7

11

Q02833
WVDGVQRIVCGVTEV

RASSF8

6

Q8NHQ8
KGEICIQDGWEGVKS

RAB39A

181

Q14964
VICTGLWCKVEGEKE

ADAMTS19

586

Q8TE59
KDRSPGQWIICVEGD

HACL1

441

Q9UJ83
WILENGKDVGIRCVG

LEMD3

581

Q9Y2U8
RGRCQEAWVLSGKQQ

RANGRF

96

Q9HD47
NRLVSGGRDCQVKVW

FBXW10B

506

O95170
VIKFCGWEQALGARV

ABCC10

471

Q5T3U5
TINIDEGGWACLVCK

NUP133

106

Q8WUM0
VILARVAVIKWGACG

LEPROT

86

O15243
GRLVKSEETVILQCW

KIR2DL2

36

P43627
IQSRIVGGWECEKHS

KLK2

21

P20151
GQVVKCWKRGTNEIV

HIPK2

211

Q9H2X6
VKAGERQWCDVGIFK

HCFC2

591

Q9Y5Z7
NEEWLEGECKGKVGI

NCF2

491

P19878
IVWEGKNENEVGRCK

GMDS

296

O60547
IVCNTLINEKWGREE

LGALS8

76

O00214
INWIEGRGKSVVCEA

HMGCR

696

P04035
SWRKVLEKCQGVVDI

EXD2

276

Q9NVH0
LCVVAGEKVWQIRVD

EXOSC9

121

Q06265
VIKVNRECVRGLWAG

PCNX3

1726

Q9H6A9
EEGGVCLWHLVKATE

PLXNB3

1651

Q9ULL4
WVDVVNRRLVVEKCG

PDZD7

181

Q9H5P4
CFVRVENVKGAVWTV

FOXP2

561

O15409
KCFVRVENVKGAVWT

FOXP1

521

Q9H334
GRLVKSEETVILQCW

KIR2DS3

36

Q14952
WKGVTVKCAAVGSIV

KLHL7

516

Q8IXQ5
EVEVGDKTAWILGAC

MEFV

656

O15553
WQVVGTVTCKCDLEG

AP5M1

231

Q9H0R1
EVGEVKSWSLGVCKE

RFPL4B

151

Q6ZWI9
QAIRKTICDWEGGRE

CYFIP2

511

Q96F07
CSDKIARWNVVGIQG

ADARB1

556

P78563
GKEVDLWACGVILFT

PHKG2

211

P15735
GEVRDKWDTVCGKSV

MACF1

6636

Q9UPN3
VGCNDGRIVIWDFLT

RBBP5

41

Q15291
GRESSIEECKIRQWG

MSR1

421

P21757
RKIVNGTCWEVVQET

BTBD18

361

B2RXH4
WGCTITALEVKDRQG

GALM

36

Q96C23
RGLWCEKGVQVLLTT

CACNG8

11

Q8WXS5
VWEAGKAGLEECLVT

IL3RA

356

P26951
IVQACRGEKHGELWV

CASP5

311

P51878
WVRGELLGSQGVCKD

COLCA1

51

Q6ZS62
VVIEDWRAQVGCEIT

FCGBP

3136

Q9Y6R7
GVVIEDWRAQVGCEI

FCGBP

4336

Q9Y6R7
IETIKGTCWQTVIDG

FBN1

846

P35555
VELSLRVWQCGGKVE

GALNT8

386

Q9NY28
SLCEILQEKGRWAGV

ADCY9

691

O60503
WKDRAETVIIGGGCV

DMGDH

46

Q9UI17
GERDWVAKKGCQRIT

IL22RA1

61

Q8N6P7
GWKIGQEVVCLAESN

GK5

321

Q6ZS86
RKGAVLVCAWAEEGA

KHK

216

P50053
TGSRDKKVVVWGECD

ELP2

686

Q6IA86
GQIKVIRKGEVSCCW

GRM1

531

Q13255
RIEIKFQGRWGTVCD

CD163

171

Q86VB7
KVCDRGWGLKEADVV

CD163

396

Q86VB7
GWGLKEADVVCRQLG

CD163

401

Q86VB7
VRGGILDVKNTCWHE

DNAH2

441

Q9P225
SKPGIWREISVCGNV

PELI1

201

Q96FA3
GRLVKSEETVILQCW

KIR2DS1

36

Q14954
VDNKVERIWGDCTVR

SARS1

151

P49591
IRRCFEGKAWGNQTI

USH2A

4191

O75445
RLEVKLGQGCFGEVW

SRC

271

P12931
LVEWKRRQQSACIGG

STAT1

236

P42224
VGNKRDLCHVREVGW

RERGL

121

Q9H628
KKIRVCVGTWNVNGG

SYNJ1

531

O43426
WCVNSVGVRRTDKGD

TACSTD2

126

P09758
RVETWDVKDVVNCVG

NBEAL2

876

Q6ZNJ1
GVQLECKGEGDVWVR

SMAD4

386

Q13485
CKGDEGGERVLQQRW

SEMA4B

286

Q9NPR2
GQKVGNEIDRSSCIW

ST6GALNAC3

91

Q8NDV1
QEVVWAVCGKLTGVL

SLC38A7

116

Q9NVC3
QRLDCWRGGQVSLKV

PMEL

56

P40967
QWSGGVAICKETRCE

SVEP1

3286

Q4LDE5
GVKKGWQRALAIVCD

CDC42BPA

1096

Q5VT25
LVTWEGDVLVCVQKG

RBP2

86

P50120
ICFTVWDVGGQDRIR

ARF4

61

P18085
KLDWVEVGLQVCRQG

PRPF8

486

Q6P2Q9
QVTCVAWVRCGVAKE

PWP1

6

Q13610
EFICWVREALGGINE

RNF213

1426

Q63HN8
VFKTEQKGWGVRCLD

SETDB2

371

Q96T68
KKQGWITVGDLEGCI

TNIK

1131

Q9UKE5
LVWDGAAGEQQVRIC

SPEG

1726

Q15772
DRTCKVWNLVTGQEI

KIF21A

1366

Q7Z4S6
WAVSDKGDVLCRLGV

TECPR1

956

Q7Z6L1
SLAKEQRLGVWCVGD

ZNF408

66

Q9H9D4
RVWELGGCANKEVLD

SRPRA

246

P08240
WGLILDICDKVGQSR

STAM

26

Q92783
GCGRATWSVREEQVK

RPS6KL1

376

Q9Y6S9
VDVTGKEAWDLGVCR

TRIM21

346

P19474
AGQVEWEKCSGIFPR

SYT10

26

Q6XYQ8
VCAVGERAGQLWSQK

FP248

126

Q71RG6
AAIGCGIVESILNWV

TOP2A

401

P11388
KEWRGACTGAVEVGQ

ZNF205

191

O95201
GKCQDGWLRGVSLVT

SH3RF2

411

Q8TEC5
RNLGIVISCWKGVCV

TMEM78

6

Q5T7P6
GGLRRAVKVQCTWSE

TRPM7

1621

Q96QT4
CEVSDENVRGVWLKN

MYBPC3

566

Q14896